• Latest Posts

Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered

M&As: what’s up with the ADC buying spree?

With $700 million Q3 rise, U.K. biotech spearheads European recovery

BioTechX 2023: the highlights

U.S. approval for psychedelic drug MDMA nears after success in clinic

Rebuilding relations: U.K. rejoins Horizon Europe to boost funding opportunities

ADVERTISEMENT

Biogen acquiring Reata Pharmaceuticals for $7.3B

FDA grants breakthrough therapy designation to Duchenne muscular dystrophy treatment

Could a natural sweetener from hydrangeas treat Alzheimer’s disease?

New CHAIN Biotech funding to aid CADD therapeutic platform

Recbio shingles vaccine clinical trial approved 

Epsilogen completes first clinical trial of IgE antibody to treat cancer

ADVERTISEMENT